GNMK

GenMark Diagnostics, Inc
GNMK

Overview Fund Activity
Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

162 hedge funds and large institutions have $974M invested in GenMark Diagnostics, Inc in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 56 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
+14
Holders Change %
+9.46%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
34
Increased
52
Reduced
56
Closed
20
Calls
$1.63M
Puts
$6.01M
Net Calls
-$4.38M
Net Calls Change
-$5.96M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$19.4M
2
Invesco
Invesco
Georgia
+$11.3M
3
AC
Armistice Capital
New York
+$11.2M
4
DCM
Driehaus Capital Management
Illinois
+$9.95M
5
Morgan Stanley
Morgan Stanley
New York
+$9.29M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$22.6M
2
PCM
Portolan Capital Management
Massachusetts
-$11M
3
O
OrbiMed
New York
-$10.8M
4
Deutsche Bank
Deutsche Bank
Germany
-$10.2M
5
PHP
Parkman Healthcare Partners
Connecticut
-$4.54M
Name Holding Trade Value Shares
Change 		Shares
Change %
AAP
176
Ardsley Advisory Partners
Connecticut
– -$147K -10,000 Closed
PCM
177
Prelude Capital Management
New York
– -$6K -440 Closed
TI
178
tru Independence
Oregon
– -$5 -376 Closed
S
179
SignatureFD
Georgia
– -$1K -89 Closed
4 5 6 7
8